Semma Therapeutics Announces Pre-Clinical Proof-of-Concept in Two Lead Programs in Type 1 Diabetes
– Stem cell-derived islets successfully reduce insulin requirements in diabetic non-human primates – – Novel device successfully protects stem cell-derived…